Of note, NSCLC patients with an altered EGFR genotype had CTC-positive cells more frequently than those with wildtype EGFR. In subpopulations of NSCLC patients with chemoresistance, HER3 and MET are expressed in CTCs. The gene discussed is ERBB3; the disease is non-small cell lung carcinoma.